|
1.
|
Nakasone T and Akeda S: The application of
deep sea water in Japan. UJNR Technical Report. 28:69–75. 1999.
|
|
2.
|
Shon YH, Kim JS and Nam KS: Inhibitory
effect of Deep-sea water on cytochrome P450 1A1, aromatase, and
MMP-9. J Life Sci. 18:503–508. 2008. View Article : Google Scholar
|
|
3.
|
Hwang HS, Kim SH, Yoo YG, et al:
Inhibitory effect of deep-sea water on differentiation of 3T3-L1
adipocytes. Mar Biotechnol (NY). 11:161–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Radhakrishnan G, Yamamoto M, Maeda H, et
al: Intake of dissolved organic matter from deep seawater inhibits
atherosclerosis progression. Biochem Biophys Res Commun. 387:25–30.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Lee KS, Shin JS, Kwon YS, Moon DS and Nam
KS: Suppression of cancer progression and metastasis in HT-29 human
colorectal adenocarcinoma by deep sea water. Biotechnol Bioproc
Eng. 18:194–200. 2013. View Article : Google Scholar
|
|
6.
|
Kohli GS, Bhargava A, Goel H, et al: Serum
magnesium levels in patients with head and neck cancer. Magnesium.
8:77–86. 1989.PubMed/NCBI
|
|
7.
|
Lappe JM, Travers-Gustafson D, Davies KM,
Recker RR and Heaney RP: Vitamin D and calcium supplementation
reduces cancer risk: results of a randomized trial. Am J Clin Nutr.
85:1586–1591. 2007.PubMed/NCBI
|
|
8.
|
Nasulewicz A, Wietrzyk J, Wolf FI, et al:
Magnesium deficiency inhibits primary tumor growth but favors
metastasis in mice. Biochim Biophys Acta. 1739:26–32. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Sartori S, Nielsen I, Tassinari D, et al:
Serum and erythrocyte magnesium concentrations in solid tumours:
relationship with stage of malignancy. Magnes Res. 5:189–192.
1992.PubMed/NCBI
|
|
10.
|
Wu K, Willett WC, Fuchs CS, Colditz GA and
Giovannucci EL: Calcium intake and risk of colon cancer in women
and men. J Natl Cancer Inst. 94:437–446. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Gamucci T, D’Ottavio AM, Magnolfi E, et
al: Weekly epirubicin plus docetaxel as first-line treatment in
metastatic breast cancer. Br J Cancer. 97:1040–1045. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Padua D and Massague J: Roles of TGFbeta
in metastasis. Cell Res. 19:89–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Shariat SF, Shalev M, Menesses-Diaz A, et
al: Preoperative plasma levels of transforming growth factor
beta(1) (TGF-beta(1)) strongly predict progression in patients
undergoing radical prostatectomy. J Clin Oncol. 19:2856–2864.
2001.
|
|
14.
|
Tsushima H, Ito N, Tamura S, et al:
Circulating transforming growth factor beta 1 as a predictor of
liver metastasis after resection in colorectal cancer. Clin Cancer
Res. 7:1258–1262. 2001.PubMed/NCBI
|
|
15.
|
Yang YA, Dukhanina O, Tang B, et al:
Lifetime exposure to a soluble TGF-beta antagonist protects mice
against metastasis without adverse side effects. J Clin Invest.
109:1607–1615. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Yin JJ, Selander K, Chirgwin JM, et al:
TGF-beta signaling blockade inhibits PTHrP secretion by breast
cancer cells and bone metastases development. J Clin Invest.
103:197–206. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Howe LR and Brown AM: Wnt signaling and
breast cancer. Cancer Biol Ther. 3:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Katoh M: Transcriptional mechanisms of
WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling
cascades. Int J Mol Med. 23:763–769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lejeune S, Huguet EL, Hamby A, Poulsom R
and Harris AL: Wnt5a cloning, expression, and up-regulation in
human primary breast cancers. Clin Cancer Res. 1:215–222.
1995.PubMed/NCBI
|
|
20.
|
Smith K, Bui TD, Poulsom R, Kaklamanis L,
Williams G and Harris AL: Up-regulation of macrophage wnt gene
expression in adenoma-carcinoma progression of human colorectal
cancer. Br J Cancer. 81:496–502. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Bittner M, Meltzer P, Chen Y, et al:
Molecular classification of cutaneous malignant melanoma by gene
expression profiling. Nature. 406:536–540. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Weeraratna AT, Jiang Y, Hostetter G, et
al: Wnt5a signaling directly affects cell motility and invasion of
metastatic melanoma. Cancer Cell. 1:279–288. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Dissanayake SK, Wade M, Johnson CE, et al:
The Wnt5A/protein kinase C pathway mediates motility in melanoma
cells via the inhibition of metastasis suppressors and initiation
of an epithelial to mesenchymal transition. J Biol Chem.
282:17259–17271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Dietrich A, Tanczos E, Vanscheidt W,
Schopf E and Simon JC: High CD44 surface expression on primary
tumours of malignant melanoma correlates with increased metastatic
risk and reduced survival. Eur J Cancer. 33:926–930. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
O’Connell MP, Fiori JL, Xu M, et al: The
orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in
metastatic melanoma. Oncogene. 29:34–44. 2010.PubMed/NCBI
|
|
26.
|
Nabeshima K, Inoue T, Shimao Y and
Sameshima T: Matrix metalloproteinases in tumor invasion: role for
cell migration. Pathol Int. 52:255–264. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Itoh T, Tanioka M, Yoshida H, Yoshioka T,
Nishimoto H and Itohara S: Reduced angiogenesis and tumor
progression in gelatinase A-deficient mice. Cancer Res.
58:1048–1051. 1998.PubMed/NCBI
|
|
28.
|
Perou CM, Sorlie T, Eisen MB, et al:
Molecular portraits of human breast tumours. Nature. 406:747–752.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Subramaniam DS and Isaacs C: Utilizing
prognostic and predictive factors in breast cancer. Curr Treat
Options Oncol. 6:147–159. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Klemm F, Bleckmann A, Siam L, et al:
beta-catenin-independent WNT signaling in basal-like breast cancer
and brain metastasis. Carcinogenesis. 32:434–442. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Kao J, Salari K, Bocanegra M, et al:
Molecular profiling of breast cancer cell lines defines relevant
tumor models and provides a resource for cancer gene discovery.
PLoS One. 4:e61462009.PubMed/NCBI
|
|
32.
|
Lei X, Yang J, Nichols RW and Sun LZ:
Abrogation of TGFbeta signaling induces apoptosis through the
modulation of MAP kinase pathways in breast cancer cells. Exp Cell
Res. 313:1687–1695. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Dumont N, Bakin AV and Arteaga CL:
Autocrine transforming growth factor-beta signaling mediates
Smad-independent motility in human cancer cells. J Biol Chem.
278:3275–3285. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Matsuda Y, Schlange T, Oakeley EJ, Boulay
A and Hynes NE: WNT signaling enhances breast cancer cell motility
and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231
xenograft growth. Breast Cancer Res. 11:R322009. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Mathiasen IS, Sergeev IN, Bastholm L,
Elling F, Norman AW and Jaattela M: Calcium and calpain as key
mediators of apoptosis-like death induced by vitamin D compounds in
breast cancer cells. J Biol Chem. 277:30738–30745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Cui Y and Rohan TE: Vitamin D, calcium,
and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev.
15:1427–1437. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Shin MH, Holmes MD, Hankinson SE, Wu K,
Colditz GA and Willett WC: Intake of dairy products, calcium, and
vitamin d and risk of breast cancer. J Natl Cancer Inst.
94:1301–1311. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Benito E, Stiggelbout A, Bosch FX, et al:
Nutritional factors in colorectal cancer risk: a case-control study
in Majorca. Int J Cancer. 49:161–167. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Negri E, La Vecchia C, D’Avanzo B and
Franceschi S: Calcium, dairy products, and colorectal cancer. Nutr
Cancer. 13:255–262. 1990. View Article : Google Scholar
|
|
41.
|
Lajer H and Daugaard G: Cisplatin and
hypomagnesemia. Cancer Treat Rev. 25:47–58. 1999. View Article : Google Scholar
|
|
42.
|
Wark PA, Lau R, Norat T and Kampman E:
Magnesium intake and colorectal tumor risk: a case-control study
and meta-analysis. Am J Clin Nutr. 96:622–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Maier JA, Nasulewicz-Goldeman A, Simonacci
M, Boninsegna A, Mazur A and Wolf FI: Insights into the mechanisms
involved in magnesium-dependent inhibition of primary tumor growth.
Nutr Cancer. 59:192–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Dai Q, Shrubsole MJ, Ness RM, et al: The
relation of magnesium and calcium intakes and a genetic
polymorphism in the magnesium transporter to colorectal neoplasia
risk. Am J Clin Nutr. 86:743–751. 2007.PubMed/NCBI
|
|
45.
|
Jang JY, Jeon YK and Kim CW: Degradation
of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of
breast cancer cells. BMC Cancer. 10:3912010. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Kang JH, Song KH, Jeong KC, et al:
Involvement of Cox-2 in the metastatic potential of
chemotherapy-resistant breast cancer cells. BMC Cancer. 11:3342011.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Li Y and Sarkar FH: Gene expression
profiles of genistein-treated PC3 prostate cancer cells. J Nutr.
132:3623–3631. 2002.PubMed/NCBI
|
|
48.
|
Suzuki A, Ozono K, Kubota T, Kondou H,
Tachikawa K and Michigami T: PTH/cAMP/PKA signaling facilitates
canonical Wnt signaling via inactivation of glycogen synthase
kinase-3beta in osteoblastic Saos-2 cells. J Cell Biochem.
104:304–317. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Takeuchi E, Tanaka T, Umemoto E, et al:
VLA-4-dependent and -independent pathways in cell contact-induced
proinflammatory cytokine production by synovial nurse-like cells
from rheumatoid arthritis patients. Arthritis Res. 4:R102002.
View Article : Google Scholar
|
